Literature DB >> 8195380

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.

G P Katsanis1, J Spargo, M J Ferraro, L Sutton, G A Jacoby.   

Abstract

Plasmids encoding extended-spectrum beta-lactamases of the TEM, SHV, and AmpC families were introduced into common Escherichia coli and Klebsiella pneumoniae hosts to create a homogeneous panel for evaluating the abilities of five test systems to detect resistance to eight beta-lactam antibiotics. Although MICs, as determined by agar dilution or E test strips, were increased and disk diffusion zone diameters were diminished, breakpoints for resistance were often not reached, and neither approach was sensitive in detecting resistance to oxyimino-beta-lactams. The MicroScan 18-h microdilution or Vitek rapid automated procedures were similarly insensitive. Ceftazidime was the best single test antibiotic for detecting extended-spectrum beta-lactamase production. beta-Lactamases TEM-7 and TEM-12 were particularly difficult to detect. Because of such difficulties, the prevalence of extended-spectrum beta-lactamases is likely to be greater than is currently appreciated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195380      PMCID: PMC263108          DOI: 10.1128/jcm.32.3.691-696.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  [Detection of extended-spectrum beta-lactamases by the rapid ATB E technique. Value of the API V2.1.1 expert system].

Authors:  P Hirtz; C Recule; P Le Noc; D Sirot; J Croize
Journal:  Pathol Biol (Paris)       Date:  1992-05

2.  Mutants of Escherichia coli requiring methionine or vitamin B12.

Authors:  B D DAVIS; E S MINGIOLI
Journal:  J Bacteriol       Date:  1950-07       Impact factor: 3.490

Review 3.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

4.  Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.

Authors:  L Gutmann; M D Kitzis; D Billot-Klein; F Goldstein; G Tran Van Nhieu; T Lu; J Carlet; E Collatz; R Williamson
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

6.  R factors from Proteus rettgeri.

Authors:  J N Coetzee; N Datta; R W Hedges
Journal:  J Gen Microbiol       Date:  1972-10

7.  Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics.

Authors:  R C Spencer; P F Wheat; T G Winstanley; D M Cox; S J Plested
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

8.  Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genes.

Authors:  L B Rice; S H Marshall; L L Carias; L Sutton; G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.

Authors:  C Brun-Buisson; P Legrand; A Philippon; F Montravers; M Ansquer; J Duval
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

10.  Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins.

Authors:  K S Meyer; C Urban; J A Eagan; B J Berger; J J Rahal
Journal:  Ann Intern Med       Date:  1993-09-01       Impact factor: 25.391

View more
  37 in total

1.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases.

Authors:  C C Randegger; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams.

Authors:  C C Randegger; A Keller; M Irla; A Wada; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.

Authors:  E Vercauteren; P Descheemaeker; M Ieven; C C Sanders; H Goossens
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

6.  Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts.

Authors:  Enno Stürenburg; Niels Storm; Ingo Sobottka; Matthias A Horstkotte; Stefanie Scherpe; Martin Aepfelbacher; Susanne Müller
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

Review 7.  Is it important to identify extended-spectrum beta-lactamase-producing isolates?

Authors:  K Bush
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

8.  Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen.

Authors:  M G Cormican; S A Marshall; R N Jones
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

9.  Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.

Authors:  G A Jacoby; P Han
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?

Authors:  E S Moland; C C Sanders; K S Thomson
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.